金浦鈦業(000545.SZ):控股股東所持3.04%股份將被司法拍賣
格隆匯5月13日丨金浦鈦業(000545.SZ)公佈,2024年5月13日,公司控股股東金浦集團收到浙江省杭州市中級人民法院網絡拍賣吿知書((2024)浙01執84號),因執行案件需要,浙江省杭州市中級人民法院將在杭州市中級人民法院淘寶網司法拍賣網絡平台上對被執行人金浦集團持有的3000萬股金浦鈦業股票(證券代碼:000545)進行第一次公開拍賣,市場價69,900,000元。
本次司法拍賣標的為公司控股股東金浦投資控股集團有限公司(簡稱“金浦集團”)持有的公司30,000,000股股份,為無限售流通股,佔其所持公司全部股份的8.87%,佔公司總股本的3.04%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.